Article citationsMore >>

Chandra J, Kuhn DM, Mukherjee PK, Hoyer LL, McCormick T, Ghannoum MA, Biofilm Formation by the Fungal Pathogen Candida albicans: Development, Architecture, and Drug Resistance, J. Bacteriol., vol. 183, no. 18, pp. 5385-5394, Sep. 2001.

has been cited by the following article:

Article

Optimising a Fusarium solani Biofilm Formation Protocol in Vitro

1Department of Biology, College of Sciences, University of Basrah, 61004, Iraq


American Journal of Infectious Diseases and Microbiology. 2018, Vol. 6 No. 2, 62-65
DOI: 10.12691/ajidm-6-2-5
Copyright © 2018 Science and Education Publishing

Cite this paper:
Marwan Y. Al-Maqtoofi. Optimising a Fusarium solani Biofilm Formation Protocol in Vitro. American Journal of Infectious Diseases and Microbiology. 2018; 6(2):62-65. doi: 10.12691/ajidm-6-2-5.

Correspondence to: Marwan  Y. Al-Maqtoofi, Department of Biology, College of Sciences, University of Basrah, 61004, Iraq. Email: marwan.almaqtoofi@outlook.com

Abstract

Opportunistic fungi belonging to the Fusarium solani have become increasingly recognised as life-threatening pathogens causing keratitis and disseminated fusariosis among both healthy individuals and patients with haematological malignancies. These infections are associated with biofilm formation on different biotic and abiotic surfaces. Considering, a biofilm is a virulence factor for causing infections, the aim of this study optimising and illustrating a simple, cost-effective and highly reproducible 96 well microtitre-based method for F. solani biofilm formation via using crystal violet stain. The results revealed that the possibility of using either 570nm or 595nm as a wavelength for quantifying fungal biofilm formation. The best time for crystal violet de-staining was 10 min of incubation. This model can be used in-vitro to quantify and understand the virulence factor of fungal biofilm during infections, and for antifungal susceptibility testing.

Keywords